Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-03-11
2021-07-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Specific Methylation Profiles in HNSCC
NCT04567056
Biomarkers in Patients With Head and Neck Cancer
NCT01466257
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486
Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer
NCT06706973
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Cancer group
20 consecutive patients with oral squamous cell carcinoma referred to the Department of Otolaryngology - Head and Neck Surgery
No interventions assigned to this group
Healthy oral mucosa group
20 controls with normal buccal mucosa upon examination.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed oral squamous cell carcinoma
* Written informed consent
* Normal buccal mucosal surface.
* Normal ENT-examination
Exclusion Criteria
* Uncontrolled comorbidity
Control group:
* History of cancer
* Uncontrolled comorbidity
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian Sander Danstrup
Associate Professor, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Gaihede, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Otolaryngology - Head and Neck Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Otolaryngology - Head and Neck Surgery
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20190047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.